
About Notitia
Notitia is a Healthcare company based in Wilmington (United States) founded in 2019 by Liping Zhao and Jeffrey Zhao. Therapeutic solutions for diabetes and infectious diseases are developed. Notitia has raised $1.5 million across 2 funding rounds. Its chief executive, as recorded, is Jeffrey Zhao. Its focus areas include Life Sciences, Diabetes and Drugs. Its legal entity is Notitia Biotechnologies Co. Its competitors include Sana Biotechnology, Semma Therapeutics and Rezolute; 2 of its 3 listed competitors have raised funding.
Company details
Notitia was founded in 2019 and is headquartered in Wilmington, United States. Operations focus on biotechnology, with therapeutic solutions developed for diabetes and infectious diseases. Key products include NBT-NM108, a high-fiber nutrient-mix drink targeted at COVID-19 and respiratory viral infections in type 2 diabetes patients, and NBT-LP306 for early-stage diabetic kidney disease. Additional solutions address Prader-Willi Syndrome.
- Headquarters Wilmington, United States
- Founders Liping Zhao, Jeffrey Zhao
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website notitiabio.com
- Social LinkedIn
- Legal Name Notitia Biotechnologies Co
- Total Equity Funding$1.5M (USD)
in 2 rounds
Funding Insights of Notitia
Notitia has successfully raised a total of $1.5M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.5M
- Total Rounds 2
- First Round $1.5M
(Nov 2020)
All 2 funding rounds of Notitia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | $1.5M | Seed | β | β | β |
| Nov 2020 | Debt – Conventional | β | β | β |
People of Notitia
6 people are tracked at Notitia (2 in leadership, 4 in board & advisors).
| Name | Role | Group |
|---|---|---|
Liping Zhao | Co-Founder | Leadership |
Jeffrey Zhao | Co-Founder & CEO | Leadership |
Gregory Stokes | Business Development Advisor | Board & advisors |
Margaret McFall-Ngai | Scientific Advisor | Board & advisors |
George Weinstock | Scientific Advisor | Board & advisors |
Jeff Miller | Scientific Advisor | Board & advisors |
Complete people profiles for Notitia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Notitia
2 dated milestones of Notitia across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Notitia is founded.
- Funding First funding round of $1.5M.
Competitors of Notitia
Notitia has 3 listed competitors in our database, 2 of them funded. They include Sana Biotechnology, Semma Therapeutics and Rezolute.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sana.com | 2018 | Seattle, United States | $821M | 328 | Genetically engineered cell therapies are developed for multiple disorders. | |
| semma-tx.com | 2015 | Cambridge, United States | $158M | 58 | Provider of bio-artificial pancreas for Type 1 Diabetes treatment | |
| rezolutebio.com | 2012 | Denver, United States | 51 | Therapies for metabolic and orphan diseases are developed by Rezolute. |
Detailed competitors of Notitia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Notitia
Websites that share an audience with Notitia (notitiabio.com).
Websites whose visitors overlap most with Notitia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sonnetbio.com | 100% | 10K | #2,355,636 | View details | |
| otradi.org | 97% | #8,709,976 | View details | ||
| synbio-tech.com | 77% | 21.9K | #1,181,176 | View details |
Top companies in Diabetes
3 companies that operate in the same segment as Notitia (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Notitia
Notitia was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Notitia is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Jeffrey Zhao is the CEO of Notitia, as recorded in our data. They have also founded this company.
Notitia is a funded company, having raised a total of $1.5M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Nov 2020.
Notitia was founded in 2019 and is headquartered in Wilmington, United States. Operations focus on biotechnology, with therapeutic solutions developed for diabetes and infectious diseases. Key products include NBT-NM108, a high-fiber nutrient-mix drink targeted at COVID-19 and respiratory viral infections in type 2 diabetes patients, and NBT-LP306 for early-stage diabetic kidney disease. Additional solutions address Prader-Willi Syndrome.
Notitia's top competitors include Sana Biotechnology, Semma Therapeutics and Rezolute.
Notitia operates through Notitia Biotechnologies Co.